References
- Illei GG, Lipsky PE. Novel, non-antigen-specific therapeutic approaches to autoimmune/inflammatory diseases. Curr Opin Immunol 2000;12:712–18.
- Taylor PC, Williams RO, Maini RN. Immunotherapy for rheumatoid arthritis. Curr Opin Immunol 2001;13:611–16.
- Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. J Am Med Assoc 2006;295:2275–85.
- Khoury M, Escriou V, Courties G, Galy A, Yao R, Largeau C, Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes. Arthritis Rheum 2008;58: 2356–67.
- Howard KA, Paludan SR, Behlke MA, Besenbacher F, Deleuran B, Kjems J. Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model. Mol Ther 2009;17:162–8.
- Simon J, Surber R, Kleinstauber G, Petrow PK, Henzgen S, Kinne RW, Systemic macrophage activation in locally-induced experimental arthritis. J Autoimmun 2001;17:127–136.
- Kinne RW, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester GR. Macrophages in rheumatoid arthritis. Arthritis Res 2000;2:189–202.
- Ye C, Abraham S, Wu H, Shankar P, Manjunath N. Silencing early viral replication in macrophages and dendritic cells effectively suppresses flavivirus encephalitis. PLoS One 2011;6:e17889.
- Kim SS, Ye C, Kumar P, Chiu I, Subramanya S, Wu H, Targeted delivery of siRNA to macrophages for anti-inflammatory treatment. Mol Ther 2010;18:993–1001.
- Bendele AM, Chlipala ES, Scherrer J, Frazier J, Sennello G, Rich WJ 3rd, Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis. Arthritis Rheum 2000;43:2648–59.
- Chia WT, Yeh LT, Chen YW, Lee HS, Chang DM, Sytwu HK. IL-1beta in irrigation fluid and mRNA expression in synovial tissue of the knee joint as therapeutic markers of inflammation in collagen antibody-induced arthritis. Dis Markers 2009;26:1–7.
- Chia WT, Chen YW, Cheng LY, Lee HS, Chang DM, Sytwu HK. MMP-9 mRNA as a therapeutic marker in acute and chronic stages of arthritis induced by type II collagen antibody. J Formos Med Assoc 2008;107:245–52.
- Conti F, Priori R, Chimenti MS, Coari G, Annovazzi A, Valesini G, Successful treatment with intraarticular infliximab for resistant knee monoarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximab. Arthritis Rheum 2005; 52: 1224–6.
- Bokarewa M, Tarkowski A. Local infusion of infliximab for the treatment of acute joint inflammation. Ann Rheum Dis 2003;62: 783–4.